ArticleZdravstveno varstvo2020
Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets.
Article in Zdravstveno varstvo, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- General and disease-specific health literacy in patients with heart failure: an outcome analysis.ESC heart failure · 2026Observational
- Translation, cultural adaptation and psychometric evaluation of the Slovene version of the Heart Failure-Specific Health Literacy Scale in patients with heart failure.Scientific reports · 2026Article
- Developing an EQ-5D-5L Value Set for Singapore.PharmacoEconomics · 2025Article
- Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024Observational
- The EQ-5D-3L Valuation Study in Pakistan.PharmacoEconomics - open · 2023Article
- EQ-5D-5L: a value set for Romania.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- In search of a 'pan-European value set'; application for EQ-5D-3L.BMC medical research methodology · 2023Article
- Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.PharmacoEconomics · 2022Review
- Age, body mass index, female gender, and patellofemoral cartilage degeneration predict worse patient outcome after patellofemoral instability surgery.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2022Article
- Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents.Applied health economics and health policy · 2022Article
- Relationship Between Quality of Life Indicators and Cardiac Status Indicators in Chemotherapy Patients.Zdravstveno varstvo · 2021Article
- Quality of Life and Health Status in Middle-aged Presumed Healthy Slovenian Family Practice Attendees.Zdravstveno varstvo · 2021Article
- Patient-reported joint status and quality of life in sports-related ankle disorders and osteoarthritis.International orthopaedics · 2021Article
- EQ-5D-Y Value Set for Slovenia.PharmacoEconomics · 2021Article
- Multiplicative modelling of EQ-5D-3L TTO and VAS values.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
- Health related QoL in celiac disease patients in Slovenia.Health and quality of life outcomes · 2020Article
- EQ-5D-5L Slovenian population norms.Health and quality of life outcomes · 2020Article
- Crosswalk EQ-5D-5L Value Set for Slovenia.Zdravstveno varstvo · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe two primary objectives of this paper were (a) to develop first logically consistent TTO based EQ-5D-3L value sets for Slovenia and (b) to revisit earlier developed VAS based EQ-5D-3L value sets.
methodsBetween September 2005 and April 2006, face-to-face interviews with 225 individuals in Slovenia were conducted. Protocols from the Measurement and Value of Health study were followed closely. Each respondent valued 15 health states out of a total of 23. Model selection was informed by the criteria monotonicity/logical consistency. Predictive accuracy was assessed in terms of mean square difference between out-of-sample predictions and corresponding observed means, as well as Lin's Concordance Correlation Coefficient.
resultsModelling was based on 2,717 VAS and 2,831 TTO values elicited from 225 respondents. A 6-parameter constrained regression model with a supplementary power term was selected for VAS and TTO value sets, as it produces monotonic values, and proved superior in terms of out-of-sample predictive accuracy over the tested alternatives.
conclusionThis is the first EQ-5D-3L TTO based value set in Slovenia and the second in Central and Eastern Europe (besides Poland). It is also the first monotonic and logically consistent VAS value set in Central and Eastern Europe. Comparisons with Polish and UK TTO values show considerable differences, mostly due to mobility with having a substantially greater weight in Slovenia. The UK value set generally produces lower values and the Polish value set higher values for mild states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.